Skip to main content
Download PDF

Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)

Breast Cancer Research volume 20, Article number: 107 (2018) Cite this article

The Original Article was published on 27 July 2018

Correction

After the publication of this article [1], we noticed that in Fig. 2, the survival curve images (C and D, lower panel) were incorrect. The corrected Fig. 2 is presented below. The correction does not affect in any our results and conclusions.

Fig. 2
figure 1

Survival curves. a Disease-free survival (DFS). b Overall survival (OS). c DFS stratified by estrogen receptor (ER) status. d OS stratified by ER status. The tentative cutoff value of 1.48 separates tumors with higher 18F-fluoromisonidazole tissue-to-blood ratio (TBR high) from those with lower 18F-fluoromisonidazole tissue-to-blood ratio (TBR low)

Full size image

Reference

  1. Asano A, Ueda S, Kuji I, Yamane T, Takeuchi H, Hirokawa E, Sugitani I, Shimada H, Hasebe T, Osaki A, et al. Intracellular hypoxia measured by (18)F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer. Breast Cancer Res. 2018;20(1):78.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Aya Asano, Shigeto Ueda and Tomohiko Yamane contributed equally to this work.

Authors and Affiliations

  1. Department of Breast Oncology, Saitama Medical University Hospital, 38 Morohongo, Moroyama-machi, Irumagun, Saitama, 350-0451, Japan

    Aya Asano & Hideki Takeuchi

  2. Department of Breast Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, 350-1241, Japan

    Shigeto Ueda, Eiko Hirokawa, Ikuko Sugitani, Hiroko Shimada, Akihiko Osaki & Toshiaki Saeki

  3. Department of Nuclear Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, 350-1241, Japan

    Ichiei Kuji & Tomohiko Yamane

  4. Department of Pathology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, 350-1241, Japan

    Takahiro Hasebe

Authors
  1. Aya Asano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shigeto Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ichiei Kuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomohiko Yamane
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hideki Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eiko Hirokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ikuko Sugitani
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroko Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Takahiro Hasebe
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Akihiko Osaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Toshiaki Saeki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ichiei Kuji.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asano, A., Ueda, S., Kuji, I. et al. Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693). Breast Cancer Res 20, 107 (2018). https://0-doi-org.brum.beds.ac.uk/10.1186/s13058-018-1038-3

Download citation

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s13058-018-1038-3

Breast Cancer Research

ISSN: 1465-542X

Contact us